You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 205181


✉ Email this page to a colleague

« Back to Dashboard


NDA 205181 describes BUTENAFINE HYDROCHLORIDE, which is a drug marketed by Taro and is included in one NDA. It is available from thirteen suppliers. Additional details are available on the BUTENAFINE HYDROCHLORIDE profile page.

The generic ingredient in BUTENAFINE HYDROCHLORIDE is butenafine hydrochloride. There are two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Summary for 205181
Tradename:BUTENAFINE HYDROCHLORIDE
Applicant:Taro
Ingredient:butenafine hydrochloride
Patents:0
Pharmacology for NDA: 205181
Suppliers and Packaging for NDA: 205181
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUTENAFINE HYDROCHLORIDE butenafine hydrochloride CREAM;TOPICAL 205181 ANDA Walgreen Company 0363-2100 0363-2100-02 1 TUBE in 1 CARTON (0363-2100-02) / 30 g in 1 TUBE
BUTENAFINE HYDROCHLORIDE butenafine hydrochloride CREAM;TOPICAL 205181 ANDA Walgreen Company 0363-2101 0363-2101-08 1 TUBE in 1 CARTON (0363-2101-08) / 12 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CREAM;TOPICALStrength1%
Approval Date:Nov 16, 2017TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.